Cargando…
Schedule-Dependent Treatment Increases Chemotherapy Efficacy in Malignant Pleural Mesothelioma
Malignant pleural mesothelioma (MPM) is a rare but aggressive thoracic malignancy with limited treatment options. One of the standard treatments for MPM is chemotherapy, which consists of concurrent treatment with pemetrexed and cisplatin. Pemetrexed limits tumor growth by inhibiting critical metabo...
Autores principales: | Karatkevich, Darya, Deng, Haibin, Gao, Yanyun, Flint, Emilio, Peng, Ren-Wang, Schmid, Ralph Alexander, Dorn, Patrick, Marti, Thomas Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569655/ https://www.ncbi.nlm.nih.gov/pubmed/36233258 http://dx.doi.org/10.3390/ijms231911949 |
Ejemplares similares
-
Endoplasmic Reticulum Stress Signaling as a Therapeutic Target in Malignant Pleural Mesothelioma
por: Xu, Duo, et al.
Publicado: (2019) -
Organoids as a Model for Precision Medicine in Malignant Pleural Mesothelioma: Where Are We Today?
por: Gao, Yanyun, et al.
Publicado: (2022) -
Therapeutic Landscape of Malignant Pleural Mesothelioma: Collateral Vulnerabilities and Evolutionary Dependencies in the Spotlight
por: Xu, Duo, et al.
Publicado: (2020) -
Biomarker-guided targeted and immunotherapies in malignant pleural mesothelioma
por: Yang, Haitang, et al.
Publicado: (2020) -
Malignant pleural mesothelioma co-opts BCL-X(L) and autophagy to escape apoptosis
por: Xu, Duo, et al.
Publicado: (2021)